CN101724069A - Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof - Google Patents
Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof Download PDFInfo
- Publication number
- CN101724069A CN101724069A CN 200910254437 CN200910254437A CN101724069A CN 101724069 A CN101724069 A CN 101724069A CN 200910254437 CN200910254437 CN 200910254437 CN 200910254437 A CN200910254437 A CN 200910254437A CN 101724069 A CN101724069 A CN 101724069A
- Authority
- CN
- China
- Prior art keywords
- yolk
- antibody
- abundance proteins
- igy
- egg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to a preparation method of a yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof; and eggs of a hen immunized by high-abundance protein are used as a source for extracting antibody. The preparation method comprises the steps of: detecting the serum potency of the immunized hen through an indirect ELISA method, obtaining an egg containing antibody with high potency after the potency meets the standard; acid hydrolyzing, freeze thawing and filtering the egg yolk liquid, and depositing by using ammonium sulphate; and further purifying through DEAE ion exchange layer chromatograph to obtain the yolk antibody IgY. The high-abundance protein of human serum/blood plasma is a high-abundance protein with albumin, IgG, transferrin, C3 alexin, IgA, IgM, trypsin, globin, lipoprotein, F factor, C9 alexin, C4 alexin, ceruloplasmin, apolipoprotein B, apolipoprotein A-1, alpha-1-acid glycoprotein, H factor, alexin factor B, prealbumin and C1q alexin, and the like, and the concentration of which are higher than 10 mug/ml.
Description
Technical field
The present invention relates to the preparation method and the application thereof of high-abundance proteins yolk antibody IgY in a kind of AHS/slurry.
Background technology
Contain organism tissue emiocytosis in human serum/biological samples such as slurry, drop to the multiple low abundance proteins in the blood, they may be the key proteins of some signal conduction and regulation and control.For example, in necrosis, apoptosis or the haemolysis process, all can there be some intracellular protein to be discharged in the blood.Carry out the serum photeomics research of disease, seek low abundance proteins, will help illustrating pathogeny, and might find the significant protein that some are relevant with the disease particular state, thereby provide novel method for the diagnosis of disease.Yet the existence of some high-abundance proteins matter, especially albumin and antibody have had a strong impact on the evaluation and the detection of low abundance proteins.
Often utilize the high-abundance proteins matter in the antibody affinity chromatography method removal sample in the proteomics research, to improve sensitivity and the resolving power that low-abundance protein is detected.The key of utilizing antibody affinity chromatography removal technology is to obtain the high and antibody cheap and easy to get of specificity, and the antibody affinity chromatography fado adopts the recombinant monoclonal or the polyclonal antibody in Mammals source now.General use rabbit, Mammalss such as mouse are as the animal-origin that produces high-abundance proteins antibody in antiserum(antisera)/blood plasma.Mammiferous Monoclonal Antibody is complicated, and output is little, the cost height; There are the problems referred to above equally in its polyclonal antibody that derives from blood plasma, and can have the shortcoming of non-specific binding.
Summary of the invention
The object of the present invention is to provide the preparation method and the application thereof of high-abundance proteins antibody in a kind of AHS/slurry, it has solved and has used rabbit in the prior art, Mammalss such as mouse are as the animal-origin that produces high-abundance proteins antibody in antiserum(antisera)/blood plasma, use mammalian blood serum as extracting antibody sources, cause the preparation process complexity of antibody, output is little, the cost height, antibody has non-specific binding, tires low and problem such as instability; And solved Mammals source antibody in albumen sepn, the non-specific separation problem that causes in the extraction.Mammals source antibody non-specific adsorption and assorted effect of signals problem of causing in immunology detection have been solved.
The thinking that the present invention addresses the above problem is: bird kind is being to have the sibship farther with Mammals in the generation, a large amount of conservative protein antigens produce and have the more antibody of high specific in can evolving at Mammals, and it is little to produce the required antigen amount of effective immune response.The egg of use hen after immunity replaces animal serum, as the source of extracting antibody.In recent years, Yolk immunoglobulin (immunoglobulin of yolk, be called for short IgY), because of output is big, high specificity, obtain conveniently, low cost and other advantages, more and more be applied to diagnosis, prevention and the treatment of disease, become a kind of reliable and stable antibody sources.The specific IgY of anti-human plasma high-abundance proteins can be covalently bonded in solid support, removes the high-abundance proteins in the blood plasma, as albumin, Transferrins,iron complexes, Fibrinogen, immunoglobulin (Ig) (IgA, IgM, IgG) etc.
The technical scheme that the present invention addresses the above problem is: the preparation method of high-abundance proteins antibody IgY may further comprise the steps in a kind of AHS/slurry that is provided:
1, collects the egg that contains high-titer antibody that hen produced after the immunity of process high-abundance proteins.The described egg that contains high-titer antibody is to determine like this: detect through the tiring of high-abundance proteins immunity stepmother chicken serum with indirect elisa method, tiring is the high-titer antibody egg after up to standard;
2, separation and Extraction high-abundance proteins yolk antibody IgY from the high-titer antibody egg: the yolk liquid of described high-titer antibody egg is dissolved through sour water, freeze thawing, filter, ammonium sulfate precipitation and DEAE anion-exchange chromatography are the separable high-abundance proteins yolk antibody IgY that obtains purifying.
The separation and Extraction of step 2 high-abundance proteins yolk antibody the steps include:
(1) albumen and the vitelline membrane of the high egg of tiring of removal obtain yolk liquid, with ultrapure water dilution yolk liquid, press ultrapure water and yolk liquid 1: 2-1: 15 volume ratio, and the pH that adjusts diluent is in the 4.5-6.0 scope, and 4 ℃ are stirred 9h to spending the night.With yolk diluent frozen after, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant through the centrifugal 20min of 11000rpm.
(2) above-mentioned supernatant liquor saturated ammonium sulphate 2 times, ultimate density is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.Dialyse the yolk antibody crude product.
(3) under 6.8～7.0 nearly neutral environment, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, be yolk antibody solution.
Step 1 pair is obtained the egg that contains high-titer antibody through the serum of immunity back hen the detection of tiring, and the steps include:
(1.1) detect immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, the minimum extent of dilution of serum with the absorbance value of positive serum 450nm during greater than 2.1 times of negative control mean values is that ELISA tires.
(1.2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
High-abundance proteins described in the present invention is an albumin, IgG, Transferrins,iron complexes, C3 complement, IgA, IgM, Trypsin, globin, lipoprotein, F-factor, C9 complement, the C4 complement, copper-protein, apolipoprotein B, aPoA-I, α-1-acid glycoprotein, the H factor, complement factor B, prealbumin, C1q complement isoconcentration is higher than the high-abundance proteins of 10 μ g/ml.
Among the present invention in AHS/slurry the high-abundance proteins yolk antibody IgY use and to comprise: the immune affinity extraction of high-abundance proteins, the immune affine separation of high-abundance proteins, the immunology detection of high-abundance proteins.
Advantage of the present invention is:
When 1, preparing the high-abundance proteins yolk antibody IgY, it is convenient to collect egg, need not blood sampling, and not damaged meets modern protection of animal rule.
2, antibody production height, it is long, with low cost to maintain the time that height tires.Lay eggs bird after immunity, can in egg, produce higher the tiring and the length of holding time soon.Yolk antibody output is big, and each egg approximately contains the above IgY of 100mg, can reach 3g in one month, is equivalent to 10-12 times of rabbit.Because the breeding expenses of bird is with cheap, and can produce high-titer antibody for a long time, its cost is well below extract corresponding antibodies from mammalian plasma.
3, antibody separation and Extraction convenience and purity are high.The Ig that does not have other in the yolk is easy to purify.The IgY crude product purity of utilizing ammonium sulfate precipitation method to be separated to just reaches more than 90%.
4, IgY is more stable, is easy to store.Because be subjected to the protection of yolk, egg is stored in following 6 months of 4 ℃ of conditions, the IgY activity has only very small loss.And IgY is more acidproof than Mammals antibody, and is alkaline-resisting, heat-resisting.
5, yolk antibody the height of tiring that the proteantigen in Mammals source is produced, high specificity, and it is little to produce the required antigen amount of effective immune response.
6, the yolk antibody of anti-high-abundance proteins is applied to the immune affinity extraction of high-abundance proteins, the immune affine separation of high-abundance proteins, the immunology detection of high-abundance proteins.The immune affinity extraction of high-abundance proteins, the immune affine separation of high-abundance proteins have been solved, the non-specific problem in the immunology detection of high-abundance proteins.
Description of drawings
Fig. 1 is a yolk antibody IgY separation and Extraction SDS-PAGE electrophorogram, the high-abundance proteins IgY that swimming lane 1 obtains for purifying, and swimming lane 2 is high-abundance proteins IgY mark product.
Embodiment
Embodiment 1 is the IgY preparation process of anti-Transferrins,iron complexes chicken:
1, the egg through hen after the Transferrins,iron complexes immunity is detected, obtain the egg that contains high-titer antibody.Concrete steps are:
(1) detect immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, the minimum extent of dilution of serum with the absorbance value of positive serum 450nm during greater than 2.1 times of negative control mean values is that ELISA tires.
(2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
2, separation and Extraction high-abundance proteins yolk antibody IgY from the high-titer antibody egg: the yolk liquid of described high-titer antibody egg is dissolved through sour water, freeze thawing, filter, ammonium sulfate precipitation and DEAE-fast-flow ion exchange chromatography are the separable high-abundance proteins yolk antibody IgY that obtains purifying.Concrete steps are:
(1) albumen and the vitelline membrane of the high egg of tiring of removal obtain yolk liquid, with ultrapure water and 1: 9 volume ratio of yolk liquid dilution yolk liquid, diluent are adjusted to about PH=5.5, and 4 ℃ are stirred 9h to spending the night.With yolk diluent frozen after, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant through the centrifugal 20min of 11000rpm.
(2) above-mentioned supernatant liquor saturated ammonium sulphate 2 times, ultimate density is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.Dialyse the yolk antibody crude product.
(3) under 6.8～7.0 nearly neutral environment, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, be yolk antibody solution.
(4) as can be seen from Figure 1, in swimming lane 1 and the swimming lane 2, same strap occurs, illustrate to extract to have obtained yolk antibody IgY in same position.
Embodiment 2 is the IgY preparation process of antialbumin chicken:
1, to the detection of tiring through the serum of hen after the albumin immunity, obtains the egg that contains high-titer antibody.Concrete steps are:
(1) detect immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, the minimum extent of dilution of serum with the absorbance value of positive serum 450nm during greater than 2.1 times of negative control mean values is that ELISA tires.
(2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
2, separation and Extraction high-abundance proteins yolk antibody IgY from the high-titer antibody egg: the yolk liquid of described high-titer antibody egg is dissolved through sour water, freeze thawing, filter, ammonium sulfate precipitation and DEAE ion exchange chromatography are the separable high-abundance proteins yolk antibody IgY that obtains purifying.
(1) albumen and the vitelline membrane of the high egg of tiring of removal obtain yolk liquid, with ultrapure water and 1: 9 volume ratio of yolk liquid dilution yolk liquid, diluent are adjusted to about PH=5.5, and 4 ℃ are stirred 9h to spending the night.With yolk diluent frozen after, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant through the centrifugal 20min of 11000rpm.
(2) above-mentioned supernatant liquor saturated ammonium sulphate 2 times, ultimate density is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.Dialyse the yolk antibody crude product.
(3) under 6.8～7.0 nearly neutral environment, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, be yolk antibody solution.
(4) as can be seen from Figure 1, in swimming lane 1 and the swimming lane 2, same strap occurs, illustrate to extract to have obtained highly purified yolk antibody IgY in same position.
Claims (5)
1. the preparation method of high-abundance proteins yolk antibody IgY in AHS/slurry, it is characterized in that: described preparation process may further comprise the steps
(1) collects the egg that contains high-titer antibody that hen produced after the immunity of process high-abundance proteins.The described egg that contains high-titer antibody is to determine like this: detect through the tiring of high-abundance proteins immunity stepmother chicken serum with indirect elisa method, tiring is the high-titer antibody egg after up to standard;
(2) imitate the anti-high-abundance proteins yolk antibody IgY of separation and Extraction the antibody egg from high price: the yolk liquid of described high-titer antibody egg is diluted through sour water, through freeze thawing, filtration obtains containing the aqueous solution of yolk antibody IgY, ammonium sulfate precipitation is slightly pure, and the DEAE ion exchange chromatography is the separable high-abundance proteins yolk antibody IgY that obtains purifying.
2. the preparation method of high-abundance proteins yolk antibody IgY in AHS according to claim 1/slurry is characterized in that: the separation and Extraction of the described high-abundance proteins yolk antibody IgY of step (2) the steps include:
(2.1) albumen and the vitelline membrane of removing the high egg of tiring obtains yolk liquid, with ultrapure water dilution yolk liquid, presses yolk liquid and ultrapure water 1: 2-1: 15 volume ratio, and diluent adjusted pH in the 4.5-6.0 scope, 4 ℃ of stirring 9h are to spending the night.With yolk diluent frozen after, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant and is the aqueous solution that contains yolk antibody IgY through the centrifugal 20min of 11000rpm.
(2.2) aqueous solution supernatant that contains yolk antibody IgY is with saturated ammonium sulphate 2 times, and final concentration is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.Dialysis obtains the yolk antibody crude product.
(2.3) under the nearly neutral environment of pH 6.8～7.0, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, obtain yolk antibody solution.
3. the preparation method of high-abundance proteins yolk antibody IgY in AHS according to claim 1/slurry, it is characterized in that: step (1) detects tiring through high-abundance proteins immunity stepmother chicken serum, obtain the egg that contains high-titer antibody, the steps include:
(1.1) detect immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, the minimum extent of dilution of serum with the absorbance value of positive serum 450nm during greater than 2.1 times of negative control mean values is that ELISA tires.
(1.2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
4. according to the preparation method of high-abundance proteins yolk antibody IgY in the arbitrary described AHS of claim 1-3/slurry, it is characterized in that: the high-abundance proteins yolk antibody IgY is used for the extraction of high-abundance proteins in AHS/slurry of preparing, separate immunology detection.
5. according to the preparation method of high-abundance proteins antibody IgY in the arbitrary described AHS of claim 1-3/slurry, it is characterized in that: described high-abundance proteins is an albumin, IgG, Transferrins,iron complexes, the C3 complement, IgA, IgM, Trypsin, globin, lipoprotein, F-factor, C9 complement, the C4 complement, copper-protein, apolipoprotein B, aPoA-I, α-1-acid glycoprotein, the H factor, complement factor B, prealbumin, Clq complement isoconcentration is higher than the high-abundance proteins of 10 μ g/ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910254437 CN101724069B (en) | 2009-12-22 | 2009-12-22 | Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910254437 CN101724069B (en) | 2009-12-22 | 2009-12-22 | Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101724069A true CN101724069A (en) | 2010-06-09 |
| CN101724069B CN101724069B (en) | 2013-03-06 |
Family
ID=42445682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200910254437 Active CN101724069B (en) | 2009-12-22 | 2009-12-22 | Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101724069B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113150129A (en) * | 2021-01-28 | 2021-07-23 | 四川大学华西医院 | Single-chain antibody of S2 protein on surface of anti-new coronavirus SARS-CoV-2 and application thereof |
| CN113264998A (en) * | 2021-01-28 | 2021-08-17 | 四川大学华西医院 | Single-chain antibody of S1 protein on surface of anti-new coronavirus SARS-CoV-2 and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1268643C (en) * | 2003-11-25 | 2006-08-09 | 中国人民解放军军事医学科学院微生物流行病研究所 | Antibody against SARS-CoV IgY and its preparing method |
| CN100347195C (en) * | 2005-06-30 | 2007-11-07 | 上海交通大学 | Preparation method of vitelline antibody for resisting pstudorabies |
| CN101343320B (en) * | 2008-07-01 | 2012-06-27 | 华南农业大学 | Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof |
| CN101564534A (en) * | 2008-11-12 | 2009-10-28 | 大连理工大学 | Specific yolk antibody preparation for controlling halitosis pathogens and application thereof |
-
2009
- 2009-12-22 CN CN 200910254437 patent/CN101724069B/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113150129A (en) * | 2021-01-28 | 2021-07-23 | 四川大学华西医院 | Single-chain antibody of S2 protein on surface of anti-new coronavirus SARS-CoV-2 and application thereof |
| CN113264998A (en) * | 2021-01-28 | 2021-08-17 | 四川大学华西医院 | Single-chain antibody of S1 protein on surface of anti-new coronavirus SARS-CoV-2 and application thereof |
| CN113150129B (en) * | 2021-01-28 | 2023-02-28 | 四川大学华西医院 | Single-chain antibody for resisting S2 protein on surface of new coronavirus SARS-CoV-2 and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101724069B (en) | 2013-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schade et al. | Polyclonal IgY antibodies from chicken egg yolk—an alternative to the production of mammalian IgG type antibodies in rabbits | |
| Nishi et al. | Purification of human, dog and rabbit α-fetoprotein by immunoadsorbents of Sepharose coupled with anti-human α-fetoprotein | |
| CN102220286B (en) | Hybridoma cell strain 2C9, anti-aflatoxin M1 monoclonal antibody produced by hybridoma cell strain 2C9 and application thereof | |
| Edelman et al. | Immunological studies of human γ-globulin: Relation of the precipitin lines of whole γ-globulin to those of the fragments produced by papain | |
| De Meulenaer et al. | Isolation and purification of chicken egg yolk immunoglobulins: a review | |
| Kim et al. | Simple separation of immunoglobulin from egg yolk by ultrafiltration | |
| CN103111094B (en) | The preparation of hexahistine label protein immunoaffinity purification enriching column and application thereof | |
| CN101724069B (en) | Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof | |
| CN101830983A (en) | Preparation and application of specific sequence-based aquaporin 4 high titer antibody | |
| CN101125886B (en) | Method for extracting yolk immunoglobulin | |
| CN103215231A (en) | Hybridoma cell strain 1H2, anti-ochratoxin A monoclonal antibody produced from same and application thereof | |
| Gee et al. | The purification of IgY from chicken egg yolk by preparative electrophoresis | |
| CN108287235A (en) | A kind of efficient, stable magnetic immuno-microsphere preparation and application | |
| US4368148A (en) | Protein PP9, process for its enrichment and its isolation and its use | |
| CN108148127A (en) | A kind of people MAP3K7IP2 polypeptides and its preparation method for antibody | |
| CN101045750B (en) | Extraction process of camel colostrum immune globulin IgA, IgG. | |
| CN1935841A (en) | Anti hepatitis B virus chicken yolk immune globulin IgY and its separating method | |
| CN103113455B (en) | Preparation and application of hemagglutinin peptide mark recombinant protein immunoaffinity purification enriching column | |
| Morgan et al. | Extraction and purification of IgY | |
| CN103071315B (en) | Preparation and application of minitype efficient salbutamol immunoaffinity purification enriching column | |
| CN101928332A (en) | Preparation method of Human HNRPA0 polypeptide and antibody thereof | |
| Phillips | Affinity chromatography in antibody and antigen purification | |
| CN105116145B (en) | A kind of method of monoclonal antibody gold mark testing inspection lily mottle virus | |
| CN103111093B (en) | The preparation of flag peptide tag recombinant protein immunoaffinity purification enriching column and application thereof | |
| CN105037524A (en) | Enrofloxacin antigen synthetic method and preparation method of enrofloxacin-IgY antibody |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: XI AN GOLDMAG NANOBIOTECH CO., LTD. Free format text: FORMER OWNER: SHAANXI BAIMEI GENE CO., LTD. Effective date: 20130718 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C56 | Change in the name or address of the patentee |
Owner name: SHAANXI BAIMEI GENE CO., LTD. Free format text: FORMER NAME: SHAANXI LIFEGEN CO., LTD. |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710069 XI AN, SHAANXI PROVINCE TO: 710077 XI AN, SHAANXI PROVINCE |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 710069 Shaanxi city of Xi'an province Taibai Road No. 229 Patentee after: SHAANXI LIFEGEN Co.,Ltd. Address before: 710069 Shaanxi city of Xi'an province Taibai Road No. 229 Patentee before: Shaanxi North American Gene Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130718 Address after: 710077, Shaanxi, Xi'an hi tech Zone, No. 85, No. 4, No. 2, modern enterprise center, 3 east side, 10402A Patentee after: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Address before: 710069 Shaanxi city of Xi'an province Taibai Road No. 229 Patentee before: SHAANXI LIFEGEN Co.,Ltd. |